Advanced High Grade Epithelial Ovarian Cancer clinical trials

Explore recruiting advanced high grade epithelial ovarian cancer clinical trials.

Recruiting advanced high grade epithelial ovarian cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced High Grade Epithelial Ovarian Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE IV TRIAL TO CONFIRM THE EFFICACY OF OLAPARIB IN COMBINATION WITH BEVACIZUMAB AS MAINTENANCE FRONTLINE TREATMENT OF HRD POSITIVE OVARIAN TUMOURS (IOLANTHE)

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Advanced High Grade Epithelial Ovarian Cancer trials by city

Advanced High Grade Epithelial Ovarian Cancer clinical trials

Recruiting advanced high grade epithelial ovarian cancer studies right now

Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

Also recruiting in Europe

A PHASE IV TRIAL TO CONFIRM THE EFFICACY OF OLAPARIB IN COMBINATION WITH BEVACIZUMAB AS MAINTENANCE FRONTLINE TREATMENT OF HRD POSITIVE OVARIAN TUMOURS (IOLANTHE)

Advanced High Grade Epithelial Ovarian Cancer trials by city

Other conditions